Special Delivery® Newsletter On-Line

Copies of the SPECIAL DELIVERY newsletters are posted on our web site for your convenience. They are available in Adobe Acrobat® Portable Document Format (PDF) and as printed hard copies. The printed version can be requested from ALZET Technical Services.

SD Volume 29.1 (Cancer Research) - May 2012 (3.6 MB)

Articles include:

  • Peptoids as anti-cancer agents
  • IL-13-PE and Gemcitabine combination therapy for pancreatic cancer

SD Volume 28.1 (Nanotechnology Research) - November 2011 (392 K)

Articles include:

  • Dendriworm delivery of siRNA with ALZET Pumps
  • High-Density lipoprotein delivery of alpha-tocopherol-conjugated siRNA

SD Volume 27.1 (Aging Research) - December 2010 (580 K)

Articles include:

  • Sirtuin Research with ALZET Pumps
  • ALZET Pumps Contribute to Stem Cell Research
  • Antiaging Effects of Rapamycin

SD Volume 26.1 - November 2009 (1.0 MB)

Articles include:

  • FGF infusion: A Novel Treatment for Diabetes and Obesity
  • Continuous Delivery of Stem Cell Factor Promotes Liver Recovery
  • Phytochemicals as Safe Therapeutic Agents for Human Diseases
  • Effective Therapeutic Gene Silencing by siRNA Infusion
  • ALZET Osmotic Pumps Aid in Siberian Tiger Conservation Research

SD Volume 25.1 (Pharmacology Research) - December 2008 (960K)

Articles include:

  • Pharmacoeconomics of Continuous Drug Administration Using ALZET Pumps
  • Dosing Methods for Antiepileptic Drugs
  • Effective Therapeutic Cannabinoid Analgesia Requires Targeted Delivery
  • Pharmacokinetics of Target-Organ Directed Drug Delivery

SD Volume 24.1 (Neuroscience Research) - October 2007 (404K)

Articles include:

  • CNS infusion of RNA molecules: a novel treatment for glioblastomas
  • Continuous Infusion of SM-216289 Improves Regeneration of Spinal Cord After Injury
  • Effective Epileptic Treatment Requires Continuous Drug Delivery
  • Tetherless Microdialysis Sampling Enabled by ALZET Pumps

SD Volume 23.1 (Cancer Research) - November 2006 (229K)

Articles include:

  • Use of ALZET pumps for successful implementation of in vivo imaging technologies
  • Enhanced immunotoxin therapy by continuous infusion of BB-3644
  • Promising new antileukemia treatment: Continuous infusion of TT-232
  • Continuous infusion optimizes triple drug therapy against colon cancer

SD Volume 22.1 - May 2002 - (384K)

Articles include:

  • Chronic Infusion of Rotenone Results in New Model of Parkinson's
  • Dissolving Rotenone for Chronic Infusion
  • Advances in Gene Therapy Research for Inner Ear Disorders
  • A Method for Chronic Drug Delivery in Neonates
  • Cyclodextrin Derivatives: Improving Delivery of Hydrophobic Compounds
  • New Agents Added to the ALZET Bibliography

SD Volume 21.1 - February 2000 - (384K)

Articles include:

  • Spontaneous Activity Directs Selection by Developing Visual Cortex Neurons
  • Intravenous Infusion in the Mouse Using ALZET Osmotic Pumps
  • Pain Research and the Role of ALZET Pumps
  • Introducing the New ALZET Brain Infusion Kit II
  • The Use of ALZET Osmotic Pumps During MRI or NMR Studies
    New Agents

SD Volume 20.2 - October 1998 - (384K)

Articles include:

  • Models of Neurodegenerative Disease
  • Nicotine as a Neuroteratogen
  • Targeted Protein Infusion (includes CGRP, HGF and oxLDL)
  • Rats and Cardiac Glycoside Sensitivity
  • New Agents in the ALZET Literature

SD Volume 20.1 - June 1998 - (288K)

Articles include:

  • Leukemia Inhibitory Factor
  • Urokinase Plasminogen Activator
  • Effective Administration of Leptin
  • Animal Models of Pediatric Hearing Loss
  • Overcoming Challenges in Neonatal Drug Delivery
  • ALZET Expert Seeks Infusion of Academia
  • New Agents in the ALZET Literature

SD Volume 19.1 - September 1997 - (345K)

Articles include:

  • Gene Delivery Using ALZET Pumps
  • VEGF Delivery in an Ischemia Model
  • In Situ Neuronal Modulation with EGF
  • Intraventricular Infusion in Mice
  • New Model 1002 Pump Available
  • Ordering Information
  • New Agents in the ALZET Literature

SD Volume 18.2 - November 1996 - (271K)

Articles include:

  • New ALZET Web Site
  • Epileptic Seizure Suppresssion
  • Antisense Inhibits Tumor Formation
  • Antisense Research Summary
  • Novel Arthritis Models

SD Volume 18.1 - March 1996 - (81K)

Articles include:

  • Manipulating the Local Nerve Environment through Targeted Delivery
  • L-Name Elucidates the Role of Nitric Oxide
  • Chronic Heavy Metal Exposure
  • Intrapericardial FGF May Salvage Ischemic Myocardium
  • Direct Delivery to the CNS 

SD Volume 17.1 - September 1995 - (101K)

Articles include:

  • Leptin Activity May be Schedule Dependent
  • Antisense Oligonucleotides Evaluated in Vivo
  • Osmotic Pumps Deployed Among the Kelp
  • Local IGF-I Infusion Restores Wound Healing



Request a custom bibliography search or select from our list of citations available on-line:

Selected quotes extracted from scientific publications describing the use of ALZET® Osmotic Pumps

“Nonspecific toxicity is a common problem associated with in vivo application of antisense oligonucleotides.However, by employing certain strategies including the use of partial rather than complete phosphorothioate modification, reducing the length of the oligonucleotide, and using a steady continuous infusion rather than bolus injections, we were able to minimize such toxicity (Van Kampen & Stoessl, 2000a).” (p. 309) Van Kampen et al., Neuroscience 2003;116:307-314.